Healthcareblogs

Market Highlights According to MRFR analysis, Healthcare Data Storage Market is expected to register a CAGR of 13.9% during the forecast period of 2019 to 2025 and is likely to be valued at USD 48.2 Billion in 2025. Healthcare data storage are software solutions used by hospitals, clinics, diagnostic centers to store patient data for future use. These solutions are used by healthcare companies to store data about manufacturing products and their processes. The growth of the global Healthcare Data Storage Market is determined by numerous factors such as an increasing patient database due to the increasing number of surgeries, increasing clinical trials, and research activities to develop innovative products. Also, the decreasing paper use to maintain patient information increases the demand for healthcare data storage solutions .   However, the key factors such as data infringement, cyber-attacks and high cost of healthcare data storage solution hamper the market growth. Ke...

  Hyperhidrosis Treatment Market to Witness a Robust Growth in the Upcoming Years Market Highlights According to MRFR analysis, Hyperhidrosis Treatment Market is expected to register a CAGR of 6.07% during the forecast period of 2019 to 2025 and is expected to reach USD 1,925.9 Million by 2025. Hyperhidrosis is a condition in which the affected person experiences excessive sweating. Hyperhidrosis can be divided into two types—primary hyperhidrosis and secondary general hyperhidrosis. Primary hyperhidrosis is the most common type, with 80% of people are affected by it. The growth of the global Hyperhidrosis Treatment Market is driven by various factors such as rising research and development activities for developing novel approaches for hyperhidrosis treatment, increasing awareness activities and campaigning about hyperhidrosis, upsurge in the usage of botulinum toxin injections, advancement in the therapeutic approaches such as laser and electronic therapy, increasing su...

  Market Highlights According to MRFR analysis, Intrauterine Contraceptive Devices (IUCDs) Market is expected to register a CAGR of 10.5% during the forecast period of 2019 to 2025 and was valued at USD 1364.0 Million in 2018. Contraceptive devices are used to prevent unwanted pregnancy by restricting the natural ovulation cycle or making changes in the egg fertilization process. Intrauterine contraceptive devices are placed inside the uterus to avoid unintended pregnancy. These devices contain a string which guarantees the precise placement of the device inside the uterus and provide aid in removal. lifespan of these devices varies as per the brands, and it can last up to 3,5 and 10 years. Plastic and metal are used in manufacturing of intrauterine contraceptive devices (IUCDs). It is available in several shapes, such as coil, loop, triangle, and T-shaped. The growth of global Intrauterine Contraceptive Devices Market is determined by numerous factors such as an increase in...

Market Highlights Increasing prevalence of epilepsy, rising number of traumatic brain injury cases, growing geriatric population, and rising healthcare expenditures are the major drivers for the global Epilepsy Diagnosis and Treatment Market Size However, high cost of therapeutic surgeries, low per capita healthcare expenditure, and lack of awareness for the disease in emerging economies are estimated to restrain the market growth during the projected period. The global Epilepsy Diagnosis and Treatment Market is estimated to grow at an approximate CAGR of 6.3% during the forecast period. Key Players The key players for the global Epilepsy Diagnosis and Treatment Market are Pfizer, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), UCB Pharma Ltd. (U.K), Abbott (U.S.), GlaxoSmithKline plc (U.K), Novartis International AG (Switzerland), Sanofi S.A. (France), Shire (Republic of Ireland), Medtronic (U.S.), NeuroWave Systems Inc. (U.S.), Natus Medical Incorporated. (U.S.), ...

  Overview: Cardiac pacemaker is a device that can manage the heart rhythm artificially. The device sends electric pulse to heart to keep the rhythm normal. Technological progress and curbed costs are major driving factor for the global cardiac pacemaker market, which is expected to garner 7.9% CAGR during the forecast period (2017-2023). Market research Future (MRFR) makes a claim in their recently published analysis of the global cardiac pacemaker market that the attainment of the valuation mark would be easier for the market during the forecast period. Several factors like growing geriatric population, better affordability, technologically-advanced devices, growing health-related issues, and others are expected to help the Cardiac Pacemaker Market   make the leap in terms of growth during the forecast period. However, the market growth can be hampered due to the necessity of surgery for the procedure, which a lot of people wish to avoid. Also, the risk of malfunctioning...

  The global osteoarthritis market is poised to capture a CAGR of approximately 6.8% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in a minutely analysed research report. The market is growing persistently on account of growing global geriatric population as it accounts for more disability among the elderly population than any other disease. Elderly patients have been reported to experience radiographic osteoarthritis which increases as patients age. Rising populace of obesity is also considered to be the driving factor in the growth of the global osteoarthritis market since obesity has also been identified as a risk factor for osteoarthritis. Obesity reduces the skeletal-weight-to-body-mass which results in compressive forces to joints. Although the treatment market for osteoarthritis is not robust, increased prevalence of the disease has resulted in increased R&D activities which are expected to bring new treatment options to the market. Mo...

  Market Overview  The global herbal medicinal products market is set to have a lucrative run at a healthy growth rate over the forecast period (2017-2023), reveals Market Research Future (MRFR).  Growth Boosters and Key Restraints  Herbal medicines products are dietary supplements or nutraceuticals with health claims in regions like North America, pre-approved by the Food and Drug Administration (FDA). FDA regulations for such products are less strict compared to traditional medicines. Therefore, favourable regulations for herbals medicinal products, mainly in North America, benefits the global herbal medicines market. Expanding geriatric population could be another factor boosting the herbal medicinal products market growth.  The elderly population in countries like Mexico and Brazil is equal to the countries in Europe and North America. This population makes extensive use of dietary supplements, a factor that will drive the sale of life cycle herbal pro...